Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-12
2006-09-12
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S394000
Reexamination Certificate
active
07105521
ABSTRACT:
The present invention provides isoeugenol derivative compounds having the moietyand having α2-adrenergic/5-HT2Aantagonist, 5-HT re-uptake inhibition, and anti-oxidant activities.
REFERENCES:
patent: 6887878 (2005-05-01), Chen
Rastogi et al. J. Med. Chem. vol. 15, p. 286-291 (1972).
Bernhardt Emily
Dykas, Shaver & Nipper, LLP
Maughan Derek H.
Nipper Stephen M.
Syn-Tech Chem & Pharm Co., Ltd.
LandOfFree
Eugenosedin-A based pharmacoligical agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Eugenosedin-A based pharmacoligical agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Eugenosedin-A based pharmacoligical agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3599127